Publications by authors named "Vito Nacci"

Claim this Profile
S
Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships.
Elena Morelli, Sandra Gemma, Roberta Budriesi, Giuseppe Campiani, Ettore Novellino, Vito Nacci

J Med Chem· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
Stefania Butini, Sandra Gemma, Giuseppe Campiani, Silvia Franceschini, Francesco Trotta, Vito Nacci

J Med Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials.
Sandra Gemma, Giuseppe Campiani, Stefania Butini, Bhupendra P Joshi, Gagan Kukreja, Vito Nacci

J Med Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
Stefania Butini, Giuseppe Campiani, Marianna Borriello, Sandra Gemma, Alessandro Panico, Vito Nacci

J Med Chem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
Caterina Fattorusso, Giuseppe Campiani, Gagan Kukreja, Marco Persico, Stefania Butini, Vito Nacci

J Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies.
Sandra Gemma, Giuseppe Campiani, Stefania Butini, Gagan Kukreja, Salvatore Sanna Coccone, Vito Nacci

J Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore.
Sandra Gemma, Giuseppe Campiani, Stefania Butini, Gagan Kukreja, Bhupendra P Joshi, Vito Nacci

J Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.
Sandra Gemma, Emanuele Gabellieri, Paul Huleatt, Caterina Fattorusso, Marianna Borriello, Vito Nacci

J Med Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivo.
Lisa M Greene, Marina Fleeton, Jude Mulligan, Chikkanna Gowda, Brian J Sheahan, Vito Nacci

Oncol Rep· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
Caterina Fattorusso, Sandra Gemma, Stefania Butini, Paul Huleatt, Bruno Catalanotti, Vito Nacci

J Med Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.
Giovanni Maga, Sandra Gemma, Caterina Fattorusso, Giada A Locatelli, Stefania Butini, Vito Nacci

Biochemistry· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrolo[1,5]benzoxa(thia)zepines as a new class of potent apoptotic agents. Biological studies and identification of an intracellular location of their drug target.
Margaret M Mc Gee, Sandra Gemma, Stefania Butini, Anna Ramunno, Daniela M Zisterer, Vito Nacci

J Med Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel atypical antipsychotic agents: rational design, an efficient palladium-catalyzed route, and pharmacological studies.
Giuseppe Campiani, Stefania Butini, Caterina Fattorusso, Francesco Trotta, Sandra Gemma, Vito Nacci

J Med Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.
Giuseppe Campiani, Caterina Fattorusso, Stefania Butini, Alessandra Gaeta, Marianna Agnusdei, Vito Nacci

J Med Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.
Margaret M Mc Gee, Lisa M Greene, Susan Ledwidge, Giuseppe Campiani, Vito Nacci

J Pharmacol Exp Ther· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Giuseppe Campiani, Stefania Butini, Caterina Fattorusso, Bruno Catalanotti, Sandra Gemma, Vito Nacci

J Med Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21.
Jude M Mulligan, Giuseppe Campiani, Anna Ramunno, Vito Nacci, Daniela M Zisterer

Biochim Biophys Acta· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuronal high-affinity sodium-dependent glutamate transporters (EAATs): targets for the development of novel therapeutics against neurodegenerative diseases.
Giuseppe Campiani, Caterina Fattorusso, Meri De Angelis, Bruno Catalanotti, Stefania Butini, Vito Nacci

Curr Pharm Des· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
Giuseppe Campiani, Stefania Butini, Francesco Trotta, Caterina Fattorusso, Bruno Catalanotti, Vito Nacci

J Med Chem· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of new molecular probes for investigation of steroid biosynthesis induced by selective interaction with peripheral type benzodiazepine receptors (PBR).
Giuseppe Campiani, Anna Ramunno, Isabella Fiorini, Vito Nacci, Elena Morelli

J Med Chem· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.
Giuseppe Campiani, Anna Ramunno, Giovanni Maga, Vito Nacci, Caterina Fattorusso

Curr Pharm Des· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells.
Margaret M Mc Gee, Giuseppe Campiani, Anna Ramunno, Vito Nacci, Mark Lawler

J Biol Chem· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspase-3 is not essential for DNA fragmentation in MCF-7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine, PBOX-6.
Margaret M Mc Gee, Edel Hyland, Giuseppe Campiani, Anna Ramunno, Vito Nacci

FEBS Lett· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrolo[1,3]benzothiazepine-based atypical antipsychotic agents. Synthesis, structure-activity relationship, molecular modeling, and biological studies.
Giuseppe Campiani, Stefania Butini, Sandra Gemma, Vito Nacci, Caterina Fattorusso

J Med Chem· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrolo-1,5-Benzoxazepines Induce Apoptosis in Chronic Myeloid Leukemia (CML) Cells by Bypassing the Apoptotic Suppressor BCR-ABL.
Margaret M Mc Gee, Giuseppe Campiani, Anna Ramunno, Caterina Fattorusso, Vito Nacci

ScientificWorldJournal· December 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis